[Federal Register Volume 86, Number 191 (Wednesday, October 6, 2021)]
[Notices]
[Page 55616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21807]



[[Page 55616]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Lead Exposure and Prevention 
Advisory Committee (LEPAC). This meeting is open to the public by 
teleconference but advance registration by November 19, 2021 is needed 
to receive the information to join the meeting. The registration link 
is https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ.

DATES: The meeting will be held on December 3, 2021, from 9:00 a.m. to 
4:15 p.m., EST.

ADDRESSES: Register in advance at https://www.zoomgov.com/webinar/register/WN_qeMSB7npRJ23PTV6t1KMtQ to receive the information to join 
the meeting.

FOR FURTHER INFORMATION CONTACT: Alexis Pullia, M.P.H., C.P.H., 
Committee Management Specialist, National Center for Environmental 
Health, CDC, 4770 Buford Highway, Atlanta, GA, 30341, Telephone: (770) 
488-3300; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water 
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27, 
Registry for Lead Exposure and Advisory Committee. The Secretary, 
Department of Health and Human Services (HHS) and by delegation, the 
Director, CDC and Administrator, NCEH/ATSDR, are authorized under 
Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27) to review 
research and Federal programs and services related to lead poisoning 
and to identify effective services and best practices for addressing 
and preventing lead exposure in communities.
    The LEPAC is charged with providing advice and guidance to the 
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on (1) 
reviewing Federal programs and services available to individual 
communities exposed to lead; (2) reviewing current research on lead 
exposure to identify additional research needs; (3) reviewing and 
identifying best practices, or the need for best practices regarding 
lead screening and the prevention of lead poisoning; (4) identifying 
effective services, including services relating to healthcare, 
education, and nutrition for individuals and communities affected by 
lead exposure and lead poisoning, including in consultation with, as 
appropriate, the lead exposure registry as established in Section 2203 
(b) of Public Law 114-322; and (5) undertaking any other review or 
activities that the Secretary determines to be appropriate.
    Matters To Be Considered: The agenda will include updates on the 
blood lead reference value, lead-related activities from Federal LEPAC 
Members, the 1988 CLIA Amendment, and from Federal environmental 
justice efforts focused on lead, a discussion of best practices for 
increasing and enhancing screening in underserved populations, and 
presentations on mapping efforts to identify populations at higher risk 
of lead exposure and Lead Safe Cleveland. Agenda items are subject to 
change as priorities dictate.

Public Participation

    Procedure for Oral Public Comment: The public comment period is 
scheduled on December 3, 2021 from 11:05 a.m. until 11:20 a.m. 
Individuals wishing to make a comment during the public comment period, 
please email your name, organization, and telephone number by November 
19, 2021, to [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-21807 Filed 10-5-21; 8:45 am]
BILLING CODE 4163-18-P